Delivery Order SPE2DE24D0013-SPE2D626F087A
- Not listed
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order valued at $1,277.84 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on July 21, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The delivery order represents a continuation of Cepheid's established relationship with federal defense and healthcare agencies as...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a delivery order valued at $3,240 from the Defense Logistics Agency Medical Supply Chain on October 31, 2025, with ultimate completion targeted for November 7, 2025. This firm fixed-price delivery order, issued under contract 4569883320 (GXTV-10), carries no set-aside designation and represents a continuation of Cepheid's substantial role as a primary federal supplier of diagnostic...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,039.40 by the Defense Logistics Agency's Medical Supply Chain on October 22, 2025, with a completion deadline of November 5, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at the contractor's Sunnyvale location. The award falls under the Defense Logistics Agency's procurement operations, which...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,757.00 firm fixed-price delivery order to Cepheid Inc. on November 5, 2025, with an ultimate completion date of November 20, 2025. This delivery order, issued without a set-aside designation, supports the agency's molecular diagnostic supply requirements and leverages Cepheid's established expertise as a primary federal supplier of diagnostic solutions. The work will be performed at Cepheid's headquarters in Sunnyvale, California....
- The Defense Logistics Agency Medical Supply Chain awarded a $2,269.40 firm fixed-price delivery order to Cepheid Inc. on October 31, 2025, with completion targeted for November 7, 2025. This delivery order, designated GXCARBAR-10, represents a continuation of Cepheid's longstanding role as a primary federal supplier of molecular diagnostic solutions, particularly for infectious disease testing and detection capabilities. The contract utilizes no set-aside designation and will be performed at...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,680 with an ultimate completion date of November 13, 2025, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, issued without a set-aside designation, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. As a manufacturer of advanced diagnostic systems and reagents, Cepheid supplies the federal...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents, was awarded a firm fixed-price delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on November 6, 2025, with an ultimate completion date of November 14, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's extensive role as a primary federal supplier of diagnostic solutions, particularly for infectious...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $1,750 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on October 29, 2025, with a completion date of November 5, 2025. The delivery order, designated GXMRSA-NXG-10 with contract number 4569867034, carries no set-aside designation and represents a continuation of Cepheid's extensive federal procurement relationship as a primary supplier of...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F087ADelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $1,750.00 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on November 10, 2025, with an ultimate completion date of November 18, 2025. This delivery order, identified as GXMRSA-NXG-10, was issued without set-aside designation and is to be performed in Sunnyvale, California. Cepheid, a leading manufacturer of advanced molecular diagnostic systems headquartered in Sunnyvale, specializes in infectious disease detection and clinical diagnostics through its GeneXpert platform. The company has established itself as a primary federal supplier across multiple healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard, providing diagnostic equipment, reagents, test kits, and maintenance services. This delivery order represents a continuation of Cepheid's substantial federal contracting relationship with the Defense Logistics Agency Medical Supply Chain, which has issued numerous delivery orders for diagnostic testing supplies, test kits, and reagents. Cepheid's federal portfolio demonstrates extensive capability in supporting the government's molecular diagnostic requirements, particularly for detecting respiratory pathogens, infectious diseases, and drug-resistant conditions. The company maintains two significant Indefinite Delivery Contracts with the Department of Veterans Affairs valued at $6.7 million and $32.8 million respectively, extending through 2029 and 2030, reflecting the government's confidence in Cepheid as a core supplier of molecular diagnostic testing capabilities across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/10/25 |